Table 4 Antimicrobial resistance of MRSA and MSSA
From: Epidemiology and microbiology of fracture-related infection: a multicenter study in Northeast China
| Antimicrobial | MRSA (n = 42) | MSSA (n = 124) | ||||
|---|---|---|---|---|---|---|
| R (%) | I (%) | S (%) | R (%) | I (%) | S (%) | |
| PEN | 100.0 | 0 | 0 | 95.2 | 0 | 4.8 |
| OXA | 100.0 | 0 | 0 | 0 | 0 | 100.0 |
| AMC | 100.0 | 0 | 0 | 0 | 0 | 100.0 |
| CRO | 100.0 | 0 | 0 | 0 | 00 | 100.0 |
| GEN | 33.3 | 4.8 | 61.9 | 21.0 | 0 | 79.0 |
| RIF | 14.3 | 0 | 85.7 | 0 | 0 | 100.0 |
| CIP | 19.0 | 9.5 | 71.4 | 14.5 | 21.0 | 64.5 |
| LVX | 19.0 | 4.8 | 76.2 | 12.9 | 0 | 87.1 |
| MFX | 19.0 | 0 | 81.0 | 12.9 | 1.6 | 85.5 |
| SXT | 14.3 | 0 | 85.7 | 1.6 | 0 | 98.4 |
| CLI | 81.0 | 0 | 19.0 | 41.9 | 3.2 | 54.9 |
| DAP | 0 | 0 | 100.0 | 0 | 0 | 100.0 |
| ERY | 85.7 | 4.8 | 9.5 | 64.5 | 1.6 | 33.9 |
| LNZ | 0 | 0 | 100.0 | 0 | 0 | 100.0 |
| VAN | 0 | 0 | 100.0 | 0 | 0 | 100.0 |
| QDA | 14.3 | 0 | 85.7 | 0 | 0 | 100.0 |
| TCY | 38.1 | 4.8 | 57.1 | 8.1 | 3.2 | 88.7 |